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Abstract
Background: Bacterial meningitis (BM) is a life-threatening disease, often related with serious complications and
sequelae. Infants and children who survive bacterial meningitis often suffer neurological and other sequelae.
Methods: A total of 2,477 patients aged 1 month to 14 years old hospitalized in a Children’s Hospital in Greece
diagnosed with acute bacterial meningitis were collected through a Meningitis Registry, from 1974 to 2005. Clinical,
laboratory and other parameters (sex, age, pathogen, duration of symptoms before and after admission) were
evaluated through univariate and multivariate analysis with regard to sequelae. Analysis of acute complications
were also studied but not included in the final model.
Results: The rate of acute complications (arthritis and/or subdural effusion) was estimated at 6.8% (152 out of
2,251 patients, 95%CI 5.8-7.9) while the rate of sequelae (severe hearing loss, ventriculitis, hydrocephalus or seizure
disorder) among survivors was estimated at 3.3% (73 out of 2,207 patients, 95%CI 2.6-4.2). Risk factors on admission
associated with sequelae included seizures, absence of hemorrhagic rash, low CSF glucose, high CSF protein and
the etiology of meningitis. A combination of significant prognostic factors including presence of seizures, low CSF
glucose, high CSF protein, positive blood culture and absence of petechiae on admission presented an absolute
risk of sequelae of 41.7% (95%CI 15.2-72.3).
Conclusions: A combination of prognostic factors of sequelae in childhood BM may be of value in selecting
patients for more intensive therapy and in identifying possible candidates for new treatment strategies.
Background
Bacterial meningitis (BM) is a life-threatening disease,
often related with serious complications and sequelae.
During the last decades the disease epidemiology has
changed dramatically in the countries that adopted the
conjugate vaccines against Haemophilus influenza type b
(Hib), Neisseria meningitidis and Streptococcus pneumo-
niae. However the impact of these vaccines on the dis-
ease epidemiology needs to be further investigated
during the next few years. Infants and children who sur-
vive bacterial meningitis suffer neurological and other
sequelae, including hearing impairment, adversely
affecting academic performance [1]. The incidence rate
(IR) of residual abnormalities in post meningitic chil-
dren is approximately 15% (with a range of 10% to 30%)
[2]. As previously reported the mean annual incidence
rate of BM in Greece throughout a period of 32 years
has been estimated to be 16.9/100,000 children, for
meningococcal meningitis 8.9/100,000 children, for
pneumococcal meningitis 1.3/100,000 children, for Hib
meningitis before conjugate vaccine 2.5 per 100,000 and
for Hib meningitis after conjugate vaccine 0.4 per
100,000 children [3].
Knowledge about factors associated with poor prog-
nosis could be valuable in selecting patients for more
intensive monitoring and treatment, in order to further
improve outcome. Several risk factors associated with
sequelae in childhood BM have been identified in
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the disease, duration of illness before admission, pre-
sence of convulsions, focal neurologic deficits, depressed
level of consciousness or absence of petechiae on admis-
sion and low cerebrospinal fluid (CSF) glucose [4-6].
However, findings of various studies are conflicting or
inconclusive, either due to the limited number of
patients or due to differences in statistical analysis (uni-
variate vs multivariate analysis).
The aim of this study was to present among others
the clinical and laboratory characteristics of a signifi-
cantly large population of children presenting with BM,
and to identify independent prognostic factors for
sequelae, by applying a multivariable analysis approach.
Methods
Ethics Statement
Data currently presented has been derived from the
Meningitis Registry (MR) of the Infectious Diseases
Department of Aghia Sophia Children’sH o s p i t a li n
Athens, Greece. The Registry Form included approxi-
mately 50 parameters that were recorded by the attend-
ing physician for each patient including demographic
data, clinical and laboratory data on admission and dur-
ing the hospital stay, treatment information, discharge
diagnosis, outcome and sequelae. Follow up visits were
conducted up to 3 months after discharge in surviving
patients and all additional information was recorded. The
detailed methodology concerning the study setting, data
collection, inclusion and exclusion criteria have been
described elsewhere [3]. This study was approved by the
ethics committee of Aghia Sofia Children’sH o s p i t a l .
Patient consent was not required since the data presented
in this study did not relate to any person or persons.
This study presents 32 years of cumulative data con-
cerning clinical presentation, laboratory findings and
prognostic factors of bacterial meningitis from patients
aged one month to 14 years of age. Data related to
treatment will be discussed elsewhere.
Definitions
A “Bacterial Meningitis case“ was defined as any patient
treated in the Infectious Diseases Department of Aghia
Sophia Children’s Hospital from January 1
st 1974 until
December 31st 2005, who was aged 1 month to 14 years
old and was diagnosed with bacterial meningitis [3].
The “Study population” included both “probable” and
“confirmed” cases.
“Probable bacterial meningitis” cases were defined -
according to World Health Organization (WHO) criteria
as those presenting clinical symptoms of meningitis (i.e.
fever, headache, stiff neck, bulging fontanelle or altered
mental status) and CSF with an elevated protein (> 100
mg/dl), decreased glucose (< 40 mg/dl) or leukocytosis
(> 100 WBC/mm3) with at least 80% neutrophils and
lacking an identifiable bacterial pathogen [7,8].
“Confirmed bacterial meningitis” cases were defined
according to WHO case definition criteria [7,8]: children
presenting with clinical symptoms of meningitis (i.e.
fever, headache, stiff neck, bulging fontanelle or mental
status changes) and identification of bacteria directly (by
c u l t u r eo rP C Rf r o mb l o o do rC S F ,o rb yc u l t u r ef r o m
the petechial lesions), or indirectly (by latex test, coun-
tercurrent immunoelectrophoresis, Phadebact (latex
agglutination), or Gram stain smear of blood or CSF).
The “Confirmed bacterial meningitis” cases were further
divided into the following groups, representing the most
commonly isolated pathogens: Neisseria meningitidis,
Streptococcus pneumoniae, Haemophilus influenzae type
b and a fourth group “confirmed bacterial meningitis
due to other bacteria” including all other isolated
pathogens.
Exclusion Criteria: Patients with recurrent meningitis
due to structural defects of the central nervous system,
or with Tuberculous meningitis were excluded from the
analysis. Patients less than one month old were also
excluded from the study.
“Fever” was defined as body temperature ≥ 38°C.
“Shock” was defined as a systolic blood pressure that
was < 2 Standard Deviations (SD) of the age-related
mean value or severely decreased peripheral perfusion
during physical examination.
“Coma” was defined as Glascow Coma Scale (GCS) <
8 or a state of profound unconsciousness in which the
child was incapable of sensing or responding to external
stimuli.
“Acute complications” were defined as the presence of
arthritis or subdural effusion. “Sequelae” were defined as
the presence of severe hearing loss, ventriculitis, hydro-
cephalus or seizure disorder, during the follow up per-
iod of 3 months.
“Arthritis” was defined as the presence of pain, swel-
ling and restriction of movement in a joint.
The term “severe hearing loss” was applied to a hear-
ing threshold of ≥ 80 dB as assessed by an audiologist.
“Seizure disorder” was defined as any convulsive disor-
der of any type that did not exist before the onset of
BM and was present during and after hospitalization.
“Bulging fontanelle“ and “grunting“ were examined in
children less than two years old.
“Meningeal signs“ were examined in children greater
than or equal to one year of age.
“Headache“ was examined in children greater than or
equal to two years old.
Study periods
For practical reasons the study was divided by date of
admission into three time intervals: period A (1974-
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1994) representing the introduction of Hib vaccine and
period C (1995-2005) representing the post Hib vaccine
era. The Hib conjugate vaccine was introduced in
Greece in mid 1994, as a result period C represents the
era after the Hib conjugate vaccine was widely used.
The heptavalent pneumococcal vaccine was introduced
in 2004.
Data analysis
Statistical analysis was performed by using the EPI-
INFO (version 3.4.3 - CDC - Atlanta) and SPSS (version
15.0 - Chicago) software. Chi-square test or Fisher’s
exact test were used to compare qualitative variables.
Student t-test or Mann-Whitney test were used for
quantitative data. All results for continuous variables are
described by using median and SD, or median and inter-
quartile range (IQR). P-values less than or equal to 0.01
were considered statistically significant in the univariate
analysis, whilst in multivariate analysis when P-values
less than 0.05 were considered statistically significant.
The association between dichotomous risk factors and
sequelae was given by using chi-square test and calculat-
ing the Absolute Risk (AR), Relative Risk (RR) and their
95% Confidence Intervals (95%CI).
T w om u l t i p l el o g i s t i cr e g r e s s i o na n a l y s e sw e r ep e r -
formed for sequelae in survivors related to risk factors
on admission and risk factors during hospitalization.
Multiple logistic regression analysis was performed
using the backward conditional method to identify pre-
dictors of sequelae. Sequelae were used as dependent
variables and candidated predictors selected when P-
values were less than 0.05 in the univariate analysis.
Moreover, we included in the logistic regression models
variables which have been reported in the literature to
be related with the prognosis of BM.
Results
Bacteriological findings
From 1974 to 2005 a total of 3,495 meningitis cases
were recorded, out of which 2,477 were classified as
bacterial in origin. A total of 1,146 cases (46.3%) were
considered as probable BM while 1,331 cases (53.7%)
were confirmed BM. The most common pathogens that
were encountered were Neisseria meningitidis (838
cases, 63.0% of confirmed BM cases), Hib (252 cases,
18.9% of confirmed BM cases), Streptococcous pneumo-
niae (186 cases, 14.0% of confirmed BM cases) and 55
cases due to “other bacteria”.
Demographics
The demographics of the study population are presented
in Table 1. The duration of symptoms before hospital
admission varied significantly (p < 0.001) according to
the pathogen of the BM. Patients with N. meningitidis
and Hib presented earlier (median = 24.0 hrs, Interquar-
tile range IQR = 20.0-48.0 hrs and median = 24.0 hrs,
IQR = 24.0-72.0 hrs, respectively) compared to patients
with meningitis due to S. pneumoniae or other bacteria
(median = 48.0 hrs, IQR = 24.0-96.0 hrs and median =
48.0 hrs, IQR = 24.0-96.0 hrs, respectively). Prior to
admission, 240 out of 2,477 patients (9.7%, 95%CI 8.6-
11.0) had already received antibiotic therapy. In those
patients the causative organism of BM was less com-
monly identified (RR 4.12, 95%CI 3.22-5.28, p < 0.001).
Moreover, the duration of symptoms with respect to the
three different periods (A, B, and C as defined earlier)
showed to be statistically significant (p < 0.001). The
duration of symptoms prior to hospital presentation was
noticed to decrease from period A (Median = 24 hrs,
I Q R=2 4 - 7 2h r s )t op e r i o dC( M e d i a n=2 4h r s ,I Q R=
18-48 hrs) (Table 2).
Clinical data
As shown in Table 1 the vast majority of cases at initial
presentation were febrile (93.2%), with an estimated
median body temperature of 39.0°C (IQR = 38.5-39.6).
Meningeal signs in children greater than or equal to one
year of age were present in 82.1% of patients on admis-
sion. Out of 838 patients with confirmed meningococcal
meningitis 511 patients (61.0%) presented with hemor-
rhagic rash. Hemorrhagic rash was also one of the pre-
senting symptoms in 17 out of 186 (9.2%) patients with
meningitis due to S. pneumoniae and 17 out of 252
(6.7%) patients with Hib meningitis. The frequency of
different clinical signs and symptoms of all registered
bacterial meningitis cases on admission are presented in
Table 1 in conjunction with laboratory findings and
other parameters.
Clinical manifestations of bacterial meningitis were
f o u n dt ob ed e p e n d e n to nt h ea g eo ft h ep a t i e n t ,a s
shown in Table 3. The most common findings in infants
included grunting (57.6%, RR 1.64, 95%CI 1.38-1.97),
poor feeding (54.7%, RR 4.93, 95%CI 4.06-5.97) and bul-
ging fontanelle (58.2%, RR 3.70, 95%CI 2.73-5.01). Sei-
zures were more common in children under one year of
age compared to older children (RR 1.70, 95%CI 1.40-
2.06), while infants presented less frequently with coma
(RR 0.49, 95%CI 0.33-0.73). Fever however, was found
to be independent of age with frequencies of fever >
90% throughout all ages as seen in Table 3.
Older children (≥ 1 years old to four years old) pre-
sented with fever (91.7%) headache (68.0%), meningeal
signs (80.8%), hemorrhagic rash (48.6%) and vomiting
(60.2%). Similar frequencies were noticed for age groups
five to nine years, and greater than ten years old inclusive.
Similar frequencies were noticed when analyzing “con-
firmed BM cases” to those of “All BM cases” for all age
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the confirmed BM population, as seen in Table 3.
Changes in clinical signs and symptoms have also
been observed during the three decades of the study.
Examination over the three different study periods (A, B
and C respectively) revealed a statistically significant
reduction in the percentage of patients that presented
with meningeal signs (80.7%, 72.6% and 51.3%, p <
Table 1 Characteristics of the study population for all BM cases
Variable N/Total* or Median (IQR) Percentage (95% CI) Missing (%)
Demographics
Age (y) 2.0 (0.5-5.0) 71/2477 (2.9)
Male sex 1450/2471 58.7% (56.7-60.6) 6/2477 (0.2)
Duration of symptoms (hrs) 24.0 (24.0-48.0) 348/2477 (14.0)
Duration of symptoms < 24 h 473/2129 22.2% (20.5-24.1) 348/2477 (14.0)
Symptoms & signs at presentation
Body temperature (°C) 39.0 (38.5-39.6) 1235/2477 (49.9)
Fever > 38 1158/1242 93.2% (91.7-94.5) 1235/2477 (49.9)
Headache
a 871/1112 78.3% (75.8-80.7) 218/1330 (16.4)
Vomiting 1193/2074 57.5% (55.4-59.7) 403/2477 (16.3)
Meningeal signs
b 1212/1477 82.1% (80.0-84.0) 214/1691 (12.7)
Haemorrhagic rash 967/2466 39.2% (37.3-41.2) 11/2477 (0.4)
Seizures 337/1777 19.0% (17.2-20.9) 700/2477 (28.3)
Bulging fontanelle
c 416/918 45.3% (42.1-48.6) 300/1218 (24.6)
Grunting
c 472/952 49.6% (46.4-52.8) 266/1218 (21.8)
Poor feeding 449/1611 27.9% (25.7-30.1) 866/2477 (35.0)
Shock 209/1689 12.4% (10.9-14.1) 788/2477 (31.8)
Coma 155/1671 9.3% (7.9-10.8) 806/2477 (32.5)
Indexes of inflammation in CSF at presentation
White-cell count (cells/mm
3) 1468.0 (268.5-5175.0) 84/2477 (3.4)
≤ 100 WBC/mm
3 396/2,393 16.5% (15.1-18.1) 84/2477 (3.4)
≤ 1000 WBC/mm
3 1063/2393 44.4% (42.4-46.4) 84/2477 (3.4)
% polymorphonuclears 88.0 (75.0-95.0) 507/2477 (20.5)
% lymphocytes 13.0 (6.0-27.0) 1282/2477 (51.8)
Glucose (mg/dl) 42.0 (18.25-58.0) 217/2477 (8.8)
Protein (mg/dl) 90.0 (42.0-190.0) 210/2477 (8.5)
Positive CSF culture 972/2082 46.7% (44.5-48.9) 395/2477 (15.9)
Positive CSF Gram stain 792/2022 39.2% (37.0-41.3) 455/2477 (18.4)
Indexes of inflammation in blood at presentation
White-cell count (cells/mm
3) 14000 (9500-19700) 186/2477 (7.5)
% polymorphonuclears 73.0 (58.0-84.0) 280/2477 (11.3)
% lymphocytes 19.0 (10.0-33.0) 456/2477 (18.4)
Positive Blood culture 284/1668 17.0% (15.3-18.9) 809/2477 (32.7)
* study population and denominators vary due to missing values.
a study population excludes children less than two years old (N = 1330)
b study population excludes children less than one year old (N = 1691)
c study population excludes children greater than or equal to two years old (N = 1218)
Table 2 Duration of symptoms according to periods
Period
A B C P-value*
Mean Median IQR Mean Median IQR Mean Median IQR
Duration of symptoms (in hours) 49.4 24 24-72 42.4 24 24-48 36.8 24 18-48 < 0.001
* Kruskal - Wallis test
Period A (1974-1984, pre Hib vaccination), Missing values: 149/1319 (11.3%)
Period B (1985-1994, Hib vaccine introduced), Missing values: 81/600 (13.5%)
Period C (1995-2005, post Hib vaccination), Missing values: 118/558 (21.1%)
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ging fontanelle (34.0%, 25.5% and 8.5%, p < 0.001),
grunting (38.0%, 34.8% and 14.4%, p < 0.001), shock
(18.6%, 5.9% and 5.9%, p < 0.001) and coma (11.7%,
7.3% and 6.2%, p = 0.002). On the contrary the rate of
hemorrhagic rash (39.1%, 34.8% and 44.1%, p = 0.006)
increased significantly in period C.
Laboratory findings
The laboratory profile of children with BM is presented in
Table 1. The results of laboratory findings and the analyses
that followed were performed on data extracted from the
Meningitis Registry, where often physicians may not have
fully completed the registry forms, therefore creating miss-
ing values in our analyses. The median value of CSF WBC
on admission was 1,468.0/mm
3 (IQR = 268.5 - 5,175.0),
while 1,063 out of 2,393 BM cases (44.4%, 95%CI 42.4 -
46.4) having less than 1,000 CSF WBC/mm
3.At o t a lo f
198 confirmed BM cases had less than or equal to 100
CSF WBC/mm
3 of which N. meningitidis were isolated in
85.9%, S. pneumoniae in 8.1%, Hib in 1.5% and other bac-
teria in 4.5% of those patients. On admission median CSF
glucose was estimated at 42.0 mg/dl (IQR = 18.5-58.0)
w i t ham e d i a nC S Fp r o t e i nv a l u eo f9 0 . 0m g / d l( I Q R=
42.0-190.0) (Table 1).
Sequelae and complications
The case fatality rate of BM for the entire study popula-
tion from all causes was estimated to be 3.8% (95/2,477,
95%CI 3.1-4.7) [3]. Case fatality rates with respect to age
groups and periods have been previously discussed in
detail [3]. The estimated case fatality rate from probable
N.meningitidis cases was 11.1% (95%CI 8.3-14.6) while
only 1.1% (95%CI 1.0-2.9) was estimated for confirmed
cases of N.meningitidis.
The rate of sequelae among survivors was estimated
3.3% (83 episodes occurred in 73/2,207 BM cases, 95%
CI 2.6-4.2). From our study, only one child out of 2,207
(0.04%) patients survived BM with major disabilities
(quadriplegia and mental retardation).
Table 3 Variations of clinical manifestations according to age
N/Total (%)
Clinical Features Age < 1 y
(n = 786)
Age 1-4 y
(n = 932)
Age 5-9 y
(n = 480)
Age > = 10 y
(n = 208)
P- value
All cases
Fever 383/408 (93.9) 421/459 (91.7) 225/236 (95.3) 101/109 (92.7) 0.303
Shock 66/541 (12.2) 84/646 (13.0) 35/317 (11.0) 18/140 (12.9) 0.849
Coma 29/525 (5.5) 58/639 (9.1) 33/317 (10.4) 32/145 (22.1) < 0.001
Bulging Fontanelle
a 371/637 (58.2) 37/235 (15.7) ---- < 0.001
Grunting
a 372/646 (57.6) 91/260 (35.0) ---- < 0.001
Poor feeding 330/603 (54.7) 103/585 (17.6) 0/257 (0.0) 4/121 (3.3) < 0.001
Seizures 155/600 (25.8) 134/678 (19.8) 24/316 (7.6) 14/137 (10.2) < 0.001
Headache
b - - 304/447 (68.0) 369/424 (87.0) 167/189 (88.4) < 0.001
Meningeal signs
c - - 655/811 (80.8) 360/426 (84.5) 151/182 (83.0) 0.252
Haemorrhagic rash 225/786 (28.6) 452/930 (48.6) 190/479 (39.7) 76/207 (36.7) < 0.001
Vomiting 269/622 (43.2) 477/792 (60.2) 289/424 (68.2) 123/179 (68.7) < 0.001
Confirmed cases
Fever 218/231 (94.4) 270/286 (94.4) 102/108 (94.4) 44/46 (95.7) 0.988
Shock 40/312 (12.8) 48/397 (12.1) 20/144 (13.9) 6/56 (10.7) 0.918
Coma 18/301 (6.0) 37/394 (9.4) 24/148 (16.2) 14/57 (24.6) < 0.001
Bulging Fontanelle
a 242/359 (67.4) 23/159 (14.5) ---- < 0.001
Grunting
a 243/369 (65.9) 66/185 (35.7) ---- < 0.001
Poor feeding 205/339 (60.5) 77/361 (21.3) 0/117 (0.0) 3/46 (6.5) < 0.001
Seizures 93/343 (27.4) 86/418 (20.6) 11/142 (7.7) 7/54 (13.0) < 0.001
Headache
b - - 174/250 (69.6) 157/183 (85.8) 66/75 (88.0) < 0.001
Meningeal signs
c - - 414/501 (82.6) 148/183 (80.9) 55/70 (78.6) 0.660
Haemorrhagic rash 119/440 (27.0) 274/570 (48.1) 102/204 (50.0) 39/80 (48.8) < 0.001
Vomiting 167/357 (46.8) 310/490 (63.3) 128/184 (69.6) 53/72 (73.6) < 0.001
a Study population excludes children ≥ 2 years old
b Study population excludes children < 2 years old
c Study population excludes children < 1 years old
There were 71 missing values in Age
Missing values ranged from 0% to 37.2%
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(152/2,251 BM cases, 95% CI 5.8-7.9) with a total of 153
episodes of complications in 152 meningitis cases. As
shown in additional file 1 arthritis and subdural effusion
were the most frequent complications (3.6% and 3.2%
respectively). The frequency of acute complications and
sequelae according to the causative agent of BM is pre-
sented in detail in additional file 1. Severe hearing loss
was diagnosed in 4 out of 160 (2.5%, 95% CI 0.7-6.3)
BM cases with pneumococcal meningitis, 7 out of 247
(2.8%, 95% CI 1.1-5.8) BM cases with Hib meningitis, 4
out of 1,104 (0.4%, 95% CI 0.1-1.0) BM cases with
meningococcal meningitisa n d1o u to f4 5( 2 . 2 % ,9 5 %
CI 0.1-11.8) BM cases with meningitis due to other bac-
teria. No difference was identified regarding sequelae
occurrence in the three time periods of the study (p =
0.410).
Prognostic factors
Analyses of the association of various clinical and
laboratory factors with sequelae are shown in Tables 4,
5 and 6. Analysis of prognostic factors with respect to
“all BM cases” and “confirmed BM cases” showed simi-
lar statistical significance for all prognostic factors as
shown in Table 4 with the exception of CSF WBC ≤
1000/μL and positive CSF culture which showed signifi-
cance only for BM cases and not for confirmed BM
cases. However, when positive CSF culture and CSF ≤
1000/ul were included in a multivariate analysis, no sta-
tistical significance was noted. Moreover, as seen in
Table 6 poor feeding with respect to sequelae showed to
be statistically significant only for BM cases and not for
confirmed BM cases.
The results of multiple logistic regression analysis are
presented in Table 7. Findings on admission including
seizures, absence of hemorrhagic rash, low CSF glucose,
high CSF protein, positive blood culture and either
pneumococcal or meningococcal meningitis were found
to be independent predictors of sequelae in survivors of
BM.
Prognostic algorithms were created using risk factors
identified in the multivariate logistic regression analysis.
Absolute and relative risk (RR) for sequelae were also
calculated. Children presenting with seizures, absence of
petechiae, low CSF glucose and a high CSF protein had
an absolute risk for sequelae of 24.5% (95%CI 16.2-34.4).
While children presenting with the above mentioned
prognostic factors in addition to positive blood cultures
had an absolute risk for sequelae of 41.7% (95%CI 15.2-
72.3) (Figure 1).
Furthermore, each acute complication or sequelae was
examined individually for the identification of indepen-
dent risk factors. Various parameters, such as causative
organism, age of patient, sex, duration of symptoms
before admission and chronological period, were ana-
lyzed with respect to occurrence of arthritis, subdural
effusion, ventriculitis, hydrocephalus, severe hearing
loss, and seizure disorder. Analysis of seizures on admis-
sion were found to be strongly associated with the
development of seizure disorder as a sequelae (RR =
8.02, 95%CI 3.40-18.96, p < 0.001), while the RR
increased to 24.77 (95%CI 10.29-59.65, p < 0.001) when
seizures occurred on the 3rd day.
Subsequently, multiple logistic regression analysis of
prognostic factors was performed for each acute compli-
cation and sequelae. It was found that meningitis due to
S. pneumoniae (OR 4.7, 95%CI 2.5-8.8), age < 1 year
(OR 18.0, 95%CI 7.7-42.3) and duration of symptoms >
24 hours (OR 2.1, 95% CI 1.2-3.8) are independent risk
factors for subdural effusion. Meningitis due to bacteria
other than N. meningitidis, S. pneumoniae and Hib (OR
15.4, 95%CI 5.7-41.4) and age < 1 year (OR 3.2, 95%CI
1.3-8.2) were found to be related with ventriculitis.
Arthritis was more common in meningococcal meningi-
tis (OR 2.8, 95%CI 1.7-4.8), while pneumococcal menin-
gitis (OR 6.0, 95%CI 1.9-19.0) and age < 1 year (OR 9.8,
95%CI 2.1-44.5) were independent risk factors for
hydrocephalus. The same risk factors, pneumococcal
meningitis (OR 12.8, 95% CI 5.6-29.0) and age < 1 year
(OR 13.7, 95%CI 4.0-46.2) were independently related
with seizure disorder.
Severe hearing loss was more common in patients
with Hib (OR 3.6, 95%CI 1.5-8.5), and pneumococcal
meningitis (OR 2.7, 95%CI 0.92-7.8; p = 0.08) although
results were not statistically significant). On the other
hand severe hearing loss was less common yet statisti-
cally significant in patients with N. meningitidis (OR 0.2,
95%CI 0.07-0.7). Although analysis of time period
showed to be significant for some sequelae, it was not
found to be an independent risk factor in multivariate
analysis.
The current study highlights various prognostic factors
of sequelae such as positive blood culture, bulging fonta-
nelle, and poor feeding that have not yet been dealt
before in previous studies.
Discussion
The present study examined clinical, laboratory and
general characteristics of children with acute BM in
order to identify independent predictors of sequelae.
Currently presented information has been extracted
from an established meningitis registry derived from an
extensive series of patients collected prospectively over a
period of 32 years in a tertiary children’s hospital [3].
Findings regarding epidemiological trends with respect
to etiology of BM, from 1974 to 2005 in Greece, have
been discussed extensively elsewhere [3]. From our
study, clinico-laboratory findings of these patients
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BM [8]. Presenting signs and symptoms depended sig-
nificantly on the age of the patient. Infants less than one
years of age presented more commonly with seizures,
bulging fontanelle, grunting and poor feeding as
expected for such an age group. However this age group
presented less commonly with coma. Toddlers and chil-
dren greater than two years of age manifested more
often with meningeal signs, headache, vomiting and hae-
morrhagic rash. Fever however was common for all age
groups, therefore it can be concluded that fever is inde-
pendent of age. It would also be feasible to suggest that
our population with fever may be somewhat lower than
it should be due to the admission of antipyretics by par-
ents prior to hospital admission.
The introduction of the Hib vaccine at the end of per-
iod B is apparent as the rate of children presenting with
seizures, bulging fontanelle, grunting, meningeal signs,
shock and coma reduced significantly in period C com-
pared to periods A and B. Improved socioeconomic
conditions resulted in increased public awareness about
the disease, improved availability of medical services,
early recognition of signs and symptoms by caregivers
and health professionals and prompt referral to tertiary
medical centres. All of these changes are reflected in a
reduction by more than 12 hours of the interval
between the onset of symptoms to hospital admission,
from period A to period C in the current study. When
considering our study group, 71.3% of Hib meningitis
cases were < 2 years of age, while patients < 5 years of
age showed a reduction of 92.5% for the incidence rate
of Hib meningitis with the introduction of Hib conju-
gate vaccine during period C (post Hib era) [3]. Hence,
it can be concluded that the reduction in the rates of
seizures, bulging fontanelle and grunting - all related to
infantile meningitis - is largely attributed to the intro-
duction and usage of Hib conjugate vaccine. Moreover,
an outbreak of serogroup C meningococcal disease that
occurred in Greece in the years 1996-1997 increased the
mean age of children affected from BM during period
Table 4 Univariate analysis of CSF and peripheral blood as prognostic factors for sequelae in childhood bacterial
meningitis
All BM cases (n = 2382) Confirmed cases (n = 1297)
Prognostic factors Sequelae/
Prognostic
factor* (%)
RR (95% CI) P-value
Sequelae/
Prognostic
factor* (%)
RR (95% CI) P-value
CSF fluid analysis at presentation
Positive CSF culture Yes 41/904 (4.5) 2.18 (1.30-3.66) 0.002 41/901 (4.5) 1.41 (0.64-3.10) 0.387
No 21/1009 (2.1) 7/217 (3.2)
Positive Gram stain Yes 41/732 (5.6) 2.86 (1.72-4.76) < 0.001 40/725 (5.5) 2.05 (1.01-4.18) 0.041
No 22/1123 (2.0) 9/335 (2.7)
CSF WBC ≤ 100/μL Yes 8/341 (2.3) 0.67 (0.32-1.37) 0.172 5/175 (2.9) 0.59 (0.24-1.45) 0.237
No 65/1843 (3.5) 50/1024 (4.9)
CSF WBC ≤ 1000/μL Yes 24/945 (2.5) 0.64 (0.40-1.04) 0.043 16/383 (4.2) 0.87 (0.49-1.54) 0.642
No 49/1239 (4.0) 39/816 (4.8)
CSF Glu < 40 mg/dL Yes 57/949 (6.0) 5.53 (2.98-0.24) < 0.001 46/665 (6.9) 4.81 (2.19-10.57) < 0.001
No 12/1104 (1.1) 7/487 (1.4)
CSF Protein > 100 mg/dL Yes 52/987 (5.3) 3.34 (1.95-5.74) < 0.001 43/646 (6.7) 3.31 (1.68-6.53) < 0.001
No 17/1078 (1.6) 10/498 (2.0)
≥ 65% neutrophils in CSF Yes 57/1534 (3.7) 1.75 (0.76-4.01) 0.119 44/911 (4.8) 1.43 (0.45-4.52) 0.383
No 6/282 (2.1) 3/89 (3.4)
Peripheral blood analysis at presentation
Positive blood culture Yes 18/256 (7.0) 3.11 (1.76-5.52) < 0.001 18/251 (7.2) 2.72 (1.41-5.25) 0.002
No 29/1284 (2.3) 16/607 (2.6)
Peripheral WBC < 5000/μL Yes 3/104 (2.9) 0.85 (0.27-2.66) 0.533 3/83 (3.6) 0.77 (0.24-2.41) 0.455
No 68/2009 (3.4) 51/1084 (4.7)
Peripheral WBC ≥ 15000/μL Yes 26/921 (2.8) 0.75 (0.47-1.20) 0.139 18/505 (3.6) 0.66 (0.38-1.14) 0.131
No 45/1192 (3.8) 36/662 (5.4)
Absolute blood neutrophil count < 1000/μL Yes 1/13 (7.7) 2.38 (0.36-5.92) 0.350 1/11 (9.1) 2.04 (0.31-13.49) 0.399
No 64/1984 (3.2) 49/1100 (4.5)
* Study population varies due to missing values
Missing values ranged from 8.3% to 35.3%
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haemorrhagic rash in the same period [9].
The case fatality rate estimated in the present study
of 3.8% is comparable to rates from other developed
c o u n t r i e s( 4 . 8 % )a sr e p o r t e di nt h em e t a - a n a l y s i sb y
Baraff et al [10]. On the other hand, the currently esti-
mated rate of sequelae overall (3.3%), is lower when
compared to other reports in the literature, which
ranges from 8% to 37% - with an average around 15%
to 17.5% [1,11-16]. Such a variation may be attributed
to the differences in the criteria adopted in each study
in the selection of its study population defined by e.g.
age, pathogen type, disease severity and even definition
of sequelae. Nevertheless, we believe that the sequelae
rates estimated in our study are possibly underesti-
mated, due to incomplete update of the registry forms
by the attending physicians, which is a known weak-
ness of disease registries. The present study supports
the current literature with respect to sequelae being
less common in meningococcal meningitis. N.meningi-
tis in our study showed to be more common but with
lower rates of sequelae. This leads to an underestima-
tion of sequelae in our series when compared to other
studies where Hib was predominant cause of meningi-
tis. This could partially explain the lower estimates of
sequelae rates in our study.
Another factor that might have influenced the low
rate of sequelae in the present study is the extensive use
of corticosteroids in our hospital for BM from the mid
70s, almost 20 years before the first prospective double-
blind studies that supported the use of dexamethasone
in childhood BM [17].
According to previous reports, hearing impairment of
any type is expected to develop in 5.6% to 30.6% of
patients with bacterial meningitis, while severe, pro-
found or bilateral hearing loss is expected to occur in
1.0 to 5.1% of patients [10,14,18-21]. These findings are
in agreement with the current study as 23 out of 2,235
children (1.0%), developed severe hearing loss.
Analyses of a large number of variables were found to
correlate with sequelae. Some of these variables that
have not been previously reported include the absence
of headache (related with septicemia and meningitis
rather than meningitis alone), bulging fontanelle, grunt-
ing and poor feeding on admission (physical signs
encountered in infants), vomiting on admission and a
positive blood culture or CSF gram stain. Moreover,
presence of meningeal signs, bulging fontanelle, grunting
or poor feeding on the 3
rd day of hospitalization (indi-
cating the occurrence of complications or sequelae such
as ventriculitis or hydrocephalus) or absence of pete-
chiae on the 3
rd day could be used as prognostic factors.
Table 5 Univariate analysis of prognostic factors for sequelae in childhood BM
All BM cases (n = 2382) Confirmed cases (n = 1297)
Prognostic Factors Sequelae/
Prognostic factor*
(%) RR (95% CI) P-value Sequelae/
Prognostic factor*
(%) RR (95% CI) P-value
Etiology
N. meningitidis Yes 15/1091 (1.4) 0.26 (0.15-0.46) < 0.001 15/763 (2.0) 0.22 (0.12-0.39) < 0.001
No 58/1116 (5.2) 40/445 (9.0)
S. pneumoniae Yes 20/161 (12.4) 4.80 (2.94-7.82) < 0.001 20/161 (12.4) 3.72 (2.20-6.27) < 0.001
No 53/2046 (2.6) 35/1047 (3.3)
H. influenzae Yes 11/240 (4.6) 1.45 (0.78-2.72) 0.163 11/240 (4.6) 1.01 (0.53-1.92) 0.980
No 62/1967 (3.2) 44/968 (4.5)
Other bacteria Yes 9/44 (20.5) 6.91 (3.68-12.99) < 0.001 9/44 (20.5) 5.18 (2.71-9.89) < 0.001
No 64/2163 (3.0) 46/1164 (4.0)
Unknown Yes 18/671 (2.7) 0.75 (0.44-1.27) 0.170 - - - - -
No 55/1536 (3.6) - -
Various Characteristics
Male sex Yes 45/1296 (3.5) 1.12 (0.71-1.79) 0.356 33/690 (4.8) 1.12 (0.66-1.90) 0.669
No 28/907 (3.1) 22/516 (4.3)
Duration of
symptoms < 24 h
Yes 5/423 (1.2) 0.32 (0.13-0.80) 0.004 3/240 (1.3) 0.24 (0.07-0.75) 0.007
No 56/1524 (3.7) 44/828 (5.3)
Age < 2 y Yes 50/1038 (4.8) 2.43 (1.49-3.99) < 0.001 39/624 (6.3) 2.15 (1.22-3.81) 0.007
No 22/1112 (2.0) 16/551 (2.9)
Period C Yes 11/384 (2.9) 0.84 (0.45-1.58) 0.364 11/247 (4.5) 0.97 (0.51-1.86) 0.933
No 62/1823 (3.4) 44/961 (4.6)
* Prognostic factor population varies due to missing values
Missing values ranged from 7.3% to 18.3%
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All BM cases (n = 2382) Confirmed cases (n = 1297)
Prognostic Factors Sequelae/prognostic
factor*
(%) RR (95% CI) P-value Sequelae/prognostic
factor*
(%) RR (95% CI) P-value
Clinical features at presentation
Fever ≥ 38°C Yes 33/1067 (3.1) 0.53 (0.19-1.46) 0.182 29/607 (4.8) 0.54 (0.17-1.69) 0.237
No 4/69 (5.8) 3/34 (8.8)
Headache
a Yes 16/796 (2.0) 0.90 (0.33-2.42) 0.501 12/386 (3.1) 1.19 (0.34-4.15) 0.536
No 5/223 (2.2) 3/115 (2.6)
Vomiting Yes 25/1102 (2.3) 0.50 (0.30-0.82) 0.004 17/631 (2.7) 0.38 (0.21-0.68) < 0.001
No 37/808 (4.6) 30/422 (7.1)
Meningeal Yes 22/1120 (2.0) 0.79 (0.32-1.92) 0.372 14/601 (2.3) 0.61 (0.23-1.68) 0.246
signs
b No 6/240 (2.5) 5/132 (3.8)
Haemorrhagic Yes 7/859 (0.8) 0.17 (0.08-0.36) < 0.001 6/505 (1.2) 0.17 (0.07-0.39) < 0.001
rash No 66/1348 (4.9) 49/703 (7.0)
Seizures Yes 33/299 (11.0) 4.61 (2.88-7.38) < 0.001 25/182 (13.7) 4.03 (2.37-6.85) < 0.001
No 32/1338 (2.4) 25/734 (3.4)
Bulging Yes 33/390 (8.5) 2.80 (1.52-5.15) < 0.001 26/256 (10.2) 2.32 (1.17-4.59) 0.012
fontanelle
c No 14/463 (3.0) 11/251 (4.4)
Grunting
c Yes 30/422 (7.1) 2.14 (1.17-3.92) 0.011 25/282 (8.9) 2.00 (1.00-3.98) 0.043
No 15/452 (3.3) 11/248 (4.4)
Poor feeding Yes 25/415 (6.0) 1.92 (1.16-3.17) 0.010 20/274 (7.3) 1.57 (0.89-2.76) 0.117
No 34/1081 (3.1) 26/558 (4.7)
Shock Yes 8/166 (4.8) 1.37 (0.66-2.84) 0.256 6/104 (5.8) 1.17 (0.51-2.71) 0.710
No 49/1392 (3.5) 38/772 (4.9)
Coma Yes 7/116 (6.0) 1.76 (0.81-3.79) 0.122 6/79 (7.6) 1.62 (0.71-3.73) 0.187
No 49/1427 (3.4) 37/791 (4.7)
Clinical features at day 3
Fever Yes 29/465 (6.2) 2.65 (1.63-4.32) < 0.001 24/305 (7.9) 2.65 (1.50-4.68) < 0.001
No 33/1404 (2.4) 21/707 (3.0)
Headache
a Yes 4/119 (3.4) 3.08 (0.94-10.07) 0.073 3/64 (4.7) 5.5 (1.14-26.65) 0.049
No 8/733 (1.1) 3/352 (0.9)
Vomiting Yes 2/22 (9.1) 3.13 (0.81-12.09) 0.139 2/15 (13.3) 3.63 (0.95-13.79) 0.110
No 45/1548 (2.9) 31/843 (3.7)
Meningeal Yes 9/252 (3.6) 3.05 (1.25-7.41) 0.015 5/141 (3.5) 3.16 (0.93-10.77) 0.066
signs
b No 10/853 (1.2) 5/446 (1.1)
Haemorrhagic Yes 1/264 (0.4) 0.11 (0.02-0.79) 0.002 1/152 (0.7) 0.15 (0.02-1.06) 0.025
rash No 42/1209 (3.5) 30/666 (4.5)
Seizures Yes 23/71 (32.4) 12.75 (7.89-20.59) < 0.001 17/49 (34.7) 10.51 (6.03-18.33) < 0.001
No 32/1259 (2.5) 23/697 (3.3)
Bulging Yes 19/109 (17.4) 4.77 (2.67-8.51) < 0.001 13/78 (16.7) 2.86 (1.49-5.49) 0.001
fontanelle
c No 22/602 (3.7) 20/343 (5.8)
Grunting
c Yes 7/25 (28.0) 6.21 (3.03-12.72) < 0.001 5/21 (23.8) 3.75 (1.60-8.77) 0.012
No 31/688 (4.5) 26/409 (6.4)
Poor feeding Yes 8/28 (28.6) 9.37 (4.80-18.27) < 0.001 7/24 (29.2) 7.26 (3.50-15.04) < 0.001
No 36/1180 (3.1) 26/647 (4.0)
Shock Yes 0/9 (0.0) 2.91 (0.44-19.10) 0.300 0/6 (0.0) 3.22 (0.51-20.42) 0.278
No 43/1250 (3.4) 31/699 (4.4)
Coma Yes 5/13 (38.5) 12.17 (5.73-25.86) < 0.001 5/11 (45.5) 11.6 (5.50-24.45) < 0.001
No 39/1234 (3.2) 27/689 (3.9)
a Study population excludes children < 2 years old,
b Study population excludes children < 1 year old,
c study population excludes children ≥ 2 years old,
* Prognostic factor population varies due to missing values
Missing values ranged from 7.3% to 38.8%
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applied in order to control the confounding influence of
other variables and to assess the independent effect of
risk factors on the outcome. Presence of seizure on
admission and on the 3
rd post-admission day increased
t h er i s ko fs e q u e l a es i g n i f i c a n t l y( O R=5 . 3 6a n dO R=
17.80 respectively). Many authors report similar find-
ings, while some correlate atypical convulsions with
later sequelae [5,11,12,16,22-24]. According to our find-
ings the occurrence of seizures on admission were
strongly associated with the development of seizure
Table 7 Multivariate analysis of prognostic factors for
sequelae in childhood bacterial meningitis
Prognostic factors OR 95% CI P value
Risk factors at presentation
Seizures 5.36 2.63-10.90 < 0.001
Hemorrhagic rash 0.21 0.06-0.69 0.011
CSF Glucose < 40 mg/dl 5.18 1.69-15.87 0.004
CSF Protein > 100 mg/dl 2.97 1.06-8.29 0.038
Positive blood culture 2.66 1.24-5.72 0.012
Note: this analysis is based on 44.7% of the study population due to missing
values
Figure 1 Absolute and relative risk for sequelae according to findings on admission.
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increased to 12.75 when seizures occurred on the 3
rd
day. Current data demonstrate that late seizures are
stronger predictors of seizure disorder.
Low CSF glucose was found to be an important prog-
nostic factor for the development of sequelae (OR =
5.18), in agreement with other studies that correlated
low CSF glucose with increased risk of hearing loss,
with increased risk of death or epilepsy, or with lower
ratio of CSF and blood glucose with increased risk of
sequelae [6,23,25]. High CSF protein considered to be
an indicator of CSF inflammation, was found to inde-
pendently predict the occurrence of sequelae (OR =
3.97), as previously reported [16]. Positive blood culture
is reported for the first time as a prognostic factor for
sequelae in children suffering from BM (OR = 2.66).
Blood cultures are not considered to be extremely inva-
sive to patients and results are available during the first
few days of hospital stay.
On multivariate analysis, either isolation of N. Menin-
gitidis or presence of hemorrhagic rash were predictors
of a favourable outcome regarding sequelae. Similar
findings have been reported in a study on risk factors
for meningococcal disease, another on the prognosis of
hearing loss, while Biesheuvel et al. incorporated the
absence of petechiae in a prediction rule for neurologi-
cal sequelae after childhood bacterial meningitis [5,6].
Similarly the role of pneumococcal meningitis as a prog-
nostic factor for sequelae in BM has also been well
documented [5,6,12]. No independent relationship was
found between young age, duration of symptoms, pre-
sence of shock or CSF WBC and sequelae.
In the present study certain combinations of prognos-
tic factors such as seizures, absence of petechiae, low
CSF glucose, high CSF protein and a positive blood cul-
ture have a significantly increased risk for sequelae.
Similarly, absence of petechiae/ecchymoses and use of
anti-epileptics for > 2 days have been used in a prognos-
tic scoring system for sequelae in childhood BM [5].
Although current study focuses on short term effects
of BM in children, several studies have pointed out the
presence of long term neurobehavioural effects. Aca-
demic, intellectual and executive ability may be nega-
tively influenced in these children, as they are found to
perform worse compared to their peers [11,26].
Our study concentrates on the prognostic factors
associated with meningitis disease in Greece only. One
of the main advantages of this study is that, by engaging
a total of 2,477 children, it turns out to be one of the
biggest cohorts of children affected with bacterial
meningitis. Such a high number of patients allows for
safe conclusions to be drawn, supported by relatively
narrow confidence intervals in the statistical analysis.
Moreover, due to the extended period that the
meningitis was in operation, we were able to delineate
long-term changes in the clinical and laboratory charac-
teristics of childhood BM. On the other hand, long
duration of the study was related with one limitation
being the lack of homogeneity in the data of the registry
forms. The use of antibiotic therapy prior to bacterial
confirmation of meningitis may also affect the results of
this study giving an under-representation of confirmed
cases. Moreover, a possible limitation of the study is the
percentage of missing values ranging from 0.4% to 35%
in different variables without having any indication that
they were created systematically. However, we have to
acknowledge that missing values is a weakness of the
analysis.
Conclusion
In conclusion, current data indicate that sequelae can be
predicted by a combination of seizures, absence of
h e m o r r h a g i cr a s h ,l o wC S Fg l u c o s e ,h i g hC S Fp r o t e i n
and a positive blood culture. Etiology is critical for the
prognosis of sequelae in childhood BM. Late findings,
including a combination of bulging fontanelle and sei-
zures on the 3
rd day also correlate with increased seque-
lae. These risk factors may be of value in selecting
patients for more intensive therapy and in identifying
possible candidates for new treatment strategies.
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